APA (7th ed.) Citation

Bakker, A., Rani, N., Mohs, R., & Gallagher, M. The HOPE4MCI study: AGB101 treatment slows progression of entorhinal cortex atrophy in APOE ε4 non‐carriers with mild cognitive impairment due to Alzheimer's disease. Wiley.

Chicago Style (17th ed.) Citation

Bakker, Arnold, Nisha Rani, Richard Mohs, and Michela Gallagher. The HOPE4MCI Study: AGB101 Treatment Slows Progression of Entorhinal Cortex Atrophy in APOE ε4 Non‐carriers with Mild Cognitive Impairment Due to Alzheimer's Disease. Wiley.

MLA (9th ed.) Citation

Bakker, Arnold, et al. The HOPE4MCI Study: AGB101 Treatment Slows Progression of Entorhinal Cortex Atrophy in APOE ε4 Non‐carriers with Mild Cognitive Impairment Due to Alzheimer's Disease. Wiley.